Factors associated with typhoid relapse in the era of multiple drug resistant strains

Kaashif Aqeeb Ahmad1, Liaqat Hayat Khan, Bakht Roshan

  • 1Pediatrix Medical Group, San Antonio, Texas, USA. kaashif_ahmad@pediatrix.com

Insights

Typhoid fever relapse is common, especially with multidrug-resistant strains. Constipation and early fever onset are key risk factors in children with MDR typhoid. Understanding these factors aids in better clinical management.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Clinical Epidemiology

Background:

  • Typhoid fever affects over 27 million people globally each year.
  • A significant clinical relapse rate of 5% to 20% is observed in typhoid cases.
  • Factors contributing to typhoid fever relapse remain largely unidentified.

Purpose of the Study:

  • To identify clinical factors associated with typhoid fever relapse in children.
  • To investigate the impact of antimicrobial resistance on relapse rates.
  • To inform clinical follow-up strategies for pediatric typhoid.

Main Methods:

  • A 15-year retrospective study of 1,650 children with culture-proven enteric fever.
  • Data collected from the Aga Khan University Medical Center, Karachi, Pakistan.
  • Analysis of clinical presentation and treatment in relation to relapse.

Main Results:

  • Constipation and presentation within 14 days of fever onset were linked to relapse in multidrug-resistant (MDR) typhoid.
  • Diarrhea was associated with decreased relapse in drug-sensitive typhoid cases.
  • Quinolone therapy also showed a protective effect against relapse in drug-sensitive strains.

Conclusions:

  • Clinical factors at presentation significantly influence typhoid fever relapse.
  • These factors may relate to changes in the reticuloendothelial system's organism load.
  • Findings are crucial for developing targeted clinical follow-up algorithms for MDR typhoid in children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...